Tofacitinib in kidney transplantation

By Wojciechowski David  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 9, 2013-09 ,pp. : 1193-1199

Informa Healthcare

Access to resources Recommend Favorite

Elucidating the Mechanism of Tofacitinib Oxidative Decyanation

By  

Drug Metabolism Letters, Vol. 10, Iss. 2, 2016-06 ,pp. : 136-143

Bentham Science Publishers

Access to resources Recommend Favorite

A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis

By Bannwarth Bernard   Kostine Marie   Poursac Nicolas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 753-761

Informa Healthcare

Access to resources Recommend Favorite

Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology

By  

Current Medicinal Chemistry, Vol. 24, Iss. 11, 2017-05 ,pp. : 1158-1167

Bentham Science Publishers

Access to resources Recommend Favorite

Single‐ and multiple‐dose pharmacokinetics of tofacitinib in healthy Chinese volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 395-399

John Wiley & Sons Inc

Access to resources Recommend Favorite